David T. Rubin, MD: Undaunted in his quest to improve the lives of patients with inflammatory bowel disease and other digestive ailments
IBD expert David T. Rubin, MD, pulls out all the stops to find the best treatment for each patient, while collaborating with colleagues on leading-edge research to find a cure.
First-of-its-kind medication shows promise for liver disease patients
UChicago Medicine experts advised and contributed to a clinical trial of resmetirom, a daily pill that improved liver fibrosis and metabolic health in some patients with liver disease.
COVID-19 information for patients with inflammatory bowel disease
University of Chicago Medicine section chief of Gastroenterology, Hepatology and Nutrition, David T. Rubin, MD, answers common questions about COVID-19 and inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis.